|
2025-03-04 |
2025-03-04 |
V
Vente
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
679
-0.7%
8,99
6 104 USD
|
679
-0.7%
|
8,99
|
6 104 USD
|
|
|
2025-03-04 |
2025-03-04 |
V
Vente
|
BASTA JAMES
EVP, General Counsel
Dirigeant
|
2 572
-2.2%
8,99
23 122 USD
|
2 572
-2.2%
|
8,99
|
23 122 USD
|
|
|
2025-01-31 |
2025-01-29 |
VP
Vente planifiée
|
Bhanji Muna
Administrateur non-exécutif
|
265
-1.3%
9,97
2 642 USD
|
265
-1.3%
|
9,97
|
2 642 USD
|
|
|
2025-01-07 |
2025-01-03 |
V
Vente
|
Dube Michael P
VP, Chief Accounting Officer
Dirigeant
|
1 372
-2.9%
12,18
16 711 USD
|
1 372
-2.9%
|
12,18
|
16 711 USD
|
|
|
2025-01-07 |
2025-01-03 |
V
Vente
|
Hicks Derek
EVP, Chief Business Officer
Dirigeant
|
6 502
-9.8%
12,18
79 194 USD
|
6 502
-9.8%
|
12,18
|
79 194 USD
|
|
|
2025-01-07 |
2025-01-03 |
V
Vente
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
26 807
-2.8%
12,18
326 509 USD
|
26 807
-2.8%
|
12,18
|
326 509 USD
|
|
|
2025-01-07 |
2025-01-03 |
V
Vente
|
BASTA JAMES
EVP, General Counsel
Dirigeant
|
7 074
-8.7%
12,18
86 161 USD
|
7 074
-8.7%
|
12,18
|
86 161 USD
|
|
|
2025-01-07 |
2025-01-03 |
V
Vente
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
9 557
-9.8%
12,18
116 404 USD
|
9 557
-9.8%
|
12,18
|
116 404 USD
|
|
|
2025-01-07 |
2025-01-03 |
V
Vente
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
8 966
-10.4%
12,18
109 206 USD
|
8 966
-10.4%
|
12,18
|
109 206 USD
|
|
|
2025-01-06 |
2025-01-03 |
V
Vente
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
7 422
-10.4%
12,18
90 400 USD
|
7 422
-10.4%
|
12,18
|
90 400 USD
|
|
|
2025-01-06 |
2025-01-02 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
556
-0.8%
12,03
6 689 USD
|
556
-0.8%
|
12,03
|
6 689 USD
|
|
|
2024-10-04 |
2024-10-02 |
V
Vente
|
Dube Michael P
VP, Chief Accounting Officer
Dirigeant
|
2 012
-4.1%
19,01
38 248 USD
|
2 012
-4.1%
|
19,01
|
38 248 USD
|
|
|
2024-07-03 |
2024-07-01 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
405
-0.6%
22,93
9 287 USD
|
405
-0.6%
|
22,93
|
9 287 USD
|
|
|
2024-06-20 |
2024-06-17 |
VP
Vente planifiée
|
Verwiel Frank
Administrateur non-exécutif
|
1 505
-7.7%
25,00
37 625 USD
|
1 505
-7.7%
|
25,00
|
37 625 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Vente
|
BASTA JAMES
EVP, General Counsel
Dirigeant
|
2 297
-2.7%
32,99
75 778 USD
|
2 297
-2.7%
|
32,99
|
75 778 USD
|
|
|
2024-03-05 |
2024-03-04 |
V
Vente
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
605
-0.8%
32,99
19 959 USD
|
605
-0.8%
|
32,99
|
19 959 USD
|
|
|
2024-01-10 |
2024-01-08 |
VP
Vente planifiée
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
667
-1.5%
29,38
19 596 USD
|
667
-1.5%
|
29,38
|
19 596 USD
|
|
|
2024-01-10 |
2024-01-08 |
VP
Vente planifiée
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
1 608
-3.5%
28,66
46 085 USD
|
1 608
-3.5%
|
28,66
|
46 085 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
Goddard Glenn
EVP, Chief Financial Officer
Dirigeant
|
5 365
-11.7%
29,46
158 053 USD
|
5 365
-11.7%
|
29,46
|
158 053 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
Hicks Derek
EVP, Chief Business Officer
Dirigeant
|
3 877
-9.5%
29,46
114 216 USD
|
3 877
-9.5%
|
29,46
|
114 216 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
5 532
-10.7%
29,46
162 973 USD
|
5 532
-10.7%
|
29,46
|
162 973 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
19 223
-2.2%
29,46
566 310 USD
|
19 223
-2.2%
|
29,46
|
566 310 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
4 301
-9.5%
29,46
126 707 USD
|
4 301
-9.5%
|
29,46
|
126 707 USD
|
|
|
2024-01-05 |
2024-01-03 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
307
-0.7%
30,12
9 247 USD
|
307
-0.7%
|
30,12
|
9 247 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
5 843
-9.7%
29,46
172 135 USD
|
5 843
-9.7%
|
29,46
|
172 135 USD
|
|
|
2024-01-05 |
2024-01-03 |
V
Vente
|
BASTA JAMES
EVP, General Counsel
Dirigeant
|
3 805
-6.9%
29,46
112 095 USD
|
3 805
-6.9%
|
29,46
|
112 095 USD
|
|
|
2023-11-02 |
2023-10-31 |
VP
Vente planifiée
|
Bhanji Muna
Administrateur non-exécutif
|
265
-2.2%
23,90
6 334 USD
|
265
-2.2%
|
23,90
|
6 334 USD
|
|
|
2023-08-02 |
2023-07-31 |
VP
Vente planifiée
|
Bhanji Muna
Administrateur non-exécutif
|
265
-2.1%
42,33
11 217 USD
|
265
-2.1%
|
42,33
|
11 217 USD
|
|
|
2023-07-10 |
2023-07-06 |
VP
Vente planifiée
|
Bhanji Muna
Administrateur non-exécutif
|
1 867
-13.0%
39,30
73 373 USD
|
1 867
-13.0%
|
39,30
|
73 373 USD
|
|
|
2023-07-06 |
2023-07-03 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
360
-0.8%
40,51
14 584 USD
|
360
-0.8%
|
40,51
|
14 584 USD
|
|
|
2023-06-22 |
2023-06-20 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
5 000
-10.0%
45,00
225 000 USD
|
5 000
-10.0%
|
45,00
|
225 000 USD
|
|
|
2023-03-03 |
2023-03-02 |
V
Vente
|
BASTA JAMES
EVP, General Counsel
Dirigeant
|
1 088
-1.9%
43,88
47 741 USD
|
1 088
-1.9%
|
43,88
|
47 741 USD
|
|
|
2023-01-06 |
2023-01-05 |
VP
Vente planifiée
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
689
-3.8%
39,10
26 940 USD
|
689
-3.8%
|
39,10
|
26 940 USD
|
|
|
2023-01-06 |
2023-01-05 |
VP
Vente planifiée
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
1 641
-8.2%
38,22
62 719 USD
|
1 641
-8.2%
|
38,22
|
62 719 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
Hicks Derek
EVP, Chief Business Officer
Dirigeant
|
1 812
-9.5%
37,21
67 425 USD
|
1 812
-9.5%
|
37,21
|
67 425 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
2 574
-9.1%
37,21
95 779 USD
|
2 574
-9.1%
|
37,21
|
95 779 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
BASTA JAMES
EVP, General Counsel
Dirigeant
|
1 138
-5.5%
37,21
42 345 USD
|
1 138
-5.5%
|
37,21
|
42 345 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
6 673
-0.9%
37,21
248 302 USD
|
6 673
-0.9%
|
37,21
|
248 302 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
2 508
-11.2%
37,21
93 323 USD
|
2 508
-11.2%
|
37,21
|
93 323 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
1 692
-10.5%
37,21
62 959 USD
|
1 692
-10.5%
|
37,21
|
62 959 USD
|
|
|
2023-01-06 |
2023-01-04 |
V
Vente
|
Goddard Glenn
EVP, Chief Financial Officer
Dirigeant
|
2 427
-13.6%
37,21
90 309 USD
|
2 427
-13.6%
|
37,21
|
90 309 USD
|
|
|
2023-01-06 |
2023-01-03 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
231
-1.4%
34,48
7 965 USD
|
231
-1.4%
|
34,48
|
7 965 USD
|
|
|
2023-01-06 |
2022-07-01 |
VP
Vente planifiée
|
Clark Eliana
EVP, Chief Technical Officer
Dirigeant
|
105
-0.6%
51,74
5 433 USD
|
105
-0.6%
|
51,74
|
5 433 USD
|
|
|
2022-03-04 |
2022-01-01 |
V
Vente
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
2 493
-0.3%
112,26
279 852 USD
|
2 493
-0.3%
|
112,26
|
279 852 USD
|
|
|
2022-03-03 |
2022-01-01 |
V
Vente
|
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer
Dirigeant
|
1 148
-19.3%
112,25
128 863 USD
|
1 148
-19.3%
|
112,25
|
128 863 USD
|
|
|
2022-03-03 |
2022-01-01 |
V
Vente
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
1 051
-8.8%
112,24
117 964 USD
|
1 051
-8.8%
|
112,24
|
117 964 USD
|
|
|
2022-03-03 |
2022-01-01 |
V
Vente
|
Goddard Glenn
EVP, Chief Financial Officer
Dirigeant
|
1 013
-33.1%
112,24
113 699 USD
|
1 013
-33.1%
|
112,24
|
113 699 USD
|
|
|
2021-11-09 |
2021-11-05 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
200
-2.2%
135,34
27 068 USD
|
200
-2.2%
|
135,34
|
27 068 USD
|
|
|
2021-11-09 |
2021-11-05 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
548
-5.8%
134,07
73 470 USD
|
548
-5.8%
|
134,07
|
73 470 USD
|
|
|
2021-11-09 |
2021-11-05 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
452
-4.6%
132,62
59 944 USD
|
452
-4.6%
|
132,62
|
59 944 USD
|
|
|
2021-11-09 |
2021-11-05 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
1 200
-10.8%
131,71
158 052 USD
|
1 200
-10.8%
|
131,71
|
158 052 USD
|
|
|
2021-10-15 |
2021-10-14 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
250
-2.8%
130,47
32 618 USD
|
250
-2.8%
|
130,47
|
32 618 USD
|
|
|
2021-10-15 |
2021-10-14 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
525
-5.5%
129,83
68 161 USD
|
525
-5.5%
|
129,83
|
68 161 USD
|
|
|
2021-10-15 |
2021-10-14 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
225
-2.3%
129,01
29 027 USD
|
225
-2.3%
|
129,01
|
29 027 USD
|
|
|
2021-10-15 |
2021-10-14 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
849
-8.0%
127,81
108 511 USD
|
849
-8.0%
|
127,81
|
108 511 USD
|
|
|
2021-10-15 |
2021-10-14 |
VP
Vente planifiée
|
Lebwohl David
EVP, Chief Medical Officer
Dirigeant
|
551
-5.0%
126,92
69 933 USD
|
551
-5.0%
|
126,92
|
69 933 USD
|
|
|
2021-10-13 |
2021-10-11 |
VP
Vente planifiée
|
Crowley John F
Administrateur non-exécutif
|
2 500
-54.4%
119,55
298 875 USD
|
2 500
-54.4%
|
119,55
|
298 875 USD
|
|
|
2021-10-07 |
2021-10-05 |
VP
Vente planifiée
|
Crowley John F
Administrateur non-exécutif
|
200
-8.7%
132,84
26 568 USD
|
200
-8.7%
|
132,84
|
26 568 USD
|
|
|
2021-10-07 |
2021-10-05 |
VP
Vente planifiée
|
Crowley John F
Administrateur non-exécutif
|
1 846
-44.6%
131,74
243 192 USD
|
1 846
-44.6%
|
131,74
|
243 192 USD
|
|
|
2021-10-07 |
2021-10-05 |
VP
Vente planifiée
|
Crowley John F
Administrateur non-exécutif
|
3 759
-47.6%
130,92
492 128 USD
|
3 759
-47.6%
|
130,92
|
492 128 USD
|
|
|
2021-10-07 |
2021-10-05 |
VP
Vente planifiée
|
Crowley John F
Administrateur non-exécutif
|
2 915
-27.0%
129,88
378 600 USD
|
2 915
-27.0%
|
129,88
|
378 600 USD
|
|
|
2021-10-07 |
2021-10-05 |
VP
Vente planifiée
|
Crowley John F
Administrateur non-exécutif
|
1 280
-10.6%
128,83
164 902 USD
|
1 280
-10.6%
|
128,83
|
164 902 USD
|
|
|
2021-09-01 |
2021-09-01 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
44 735
-5.9%
170,00
7 604 950 USD
|
44 735
-5.9%
|
170,00
|
7 604 950 USD
|
|
|
2021-09-01 |
2021-08-31 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
37 833
-5.0%
155,00
5 864 115 USD
|
37 833
-5.0%
|
155,00
|
5 864 115 USD
|
|
|
2021-09-01 |
2021-08-31 |
VP
Vente planifiée
|
Goddard Glenn
EVP, Chief Financial Officer
Dirigeant
|
24 800
-100.0%
160,22
3 973 456 USD
|
24 800
-100.0%
|
160,22
|
3 973 456 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
216
-0.0%
160,69
34 709 USD
|
216
-0.0%
|
160,69
|
34 709 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
725
-0.1%
159,98
115 986 USD
|
725
-0.1%
|
159,98
|
115 986 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
2 598
-0.4%
159,18
413 550 USD
|
2 598
-0.4%
|
159,18
|
413 550 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
3 123
-0.4%
157,75
492 653 USD
|
3 123
-0.4%
|
157,75
|
492 653 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
4 758
-0.7%
156,96
746 816 USD
|
4 758
-0.7%
|
156,96
|
746 816 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
15 567
-2.1%
155,70
2 423 782 USD
|
15 567
-2.1%
|
155,70
|
2 423 782 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
7 428
-1.0%
154,98
1 151 191 USD
|
7 428
-1.0%
|
154,98
|
1 151 191 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
2 334
-0.3%
153,66
358 642 USD
|
2 334
-0.3%
|
153,66
|
358 642 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
LEONARD JOHN M
President and CEO
Administrateur exécutif
|
2 055
-0.3%
152,81
314 025 USD
|
2 055
-0.3%
|
152,81
|
314 025 USD
|
|
|
2021-09-01 |
2021-08-30 |
VP
Vente planifiée
|
Goddard Glenn
EVP, Chief Financial Officer
Dirigeant
|
300
-100.0%
160,84
48 252 USD
|
300
-100.0%
|
160,84
|
48 252 USD
|
|
